3rd Quarter - Report

CARDINAL HEALTH, INC. for CARDINAL HEALTH INC

Firm
Client
Income
—
Expenses
$390,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine and issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025).

LobbyistCovered position, as disclosed
ABIGAIL BARNES —
ANGELEINE COMTE —
JERRICA MATHIS —
REBECCA MCGRATH —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 4299 (119th), H.R. 5031 (119th), H.R. 5142 (119th), H.R. 3164 (119th), S. 2426 (119th)

Manufacturing MAN

Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.

LobbyistCovered position, as disclosed
ABIGAIL BARNES —
ANGELEINE COMTE —
JERRICA MATHIS —
REBECCA MCGRATH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Issues related to tariffs, trade, and U.S. trade policy.

LobbyistCovered position, as disclosed
ABIGAIL BARNES —
ANGELEINE COMTE —
JERRICA MATHIS —
REBECCA MCGRATH —

Contacted: SENATE; U.S. Trade Representative (USTR); White House Office; Treasury, Dept of; Commerce, Dept of (DOC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Tariff (miscellaneous tariff bills) TAR

Issues related to tariffs, trade, and U.S. trade policy.

LobbyistCovered position, as disclosed
ABIGAIL BARNES —
ANGELEINE COMTE —
JERRICA MATHIS —
REBECCA MCGRATH —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Commerce, Dept of (DOC); Treasury, Dept of; White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.